ipacef
international pharmaceuticals associated s.r.l. - cefuroxime - cefuroxime
deltacef
pulitzer italiana s.r.l. - cefuroxime - cefuroxime
biofurex
k.b.r. kroton biologic researches s.r.l. - cefuroxime - cefuroxime
lifurox
eli lilly italia s.p.a. - cefuroxime - cefuroxime
zinocep
glaxo allen s.p.a. - cefuroxime - cefuroxime
zinnat
sandoz s.p.a. - cefuroxime - cefuroxime
tilexim
i.b.n. savio s.r.l - cefuroxime - cefuroxime
tafinlar 10 mg tablette zur herstellung einer suspension zum einnehmen
novartis pharma schweiz ag - dabrafenibum - tablette zur herstellung einer suspension zum einnehmen - dabrafenibum 10 mg ut dabrafenibi mesilas, mannitolum, cellulosum microcristallinum, crospovidonum, hypromellosum, acesulfamum kalicum magnesii stearas, silica colloidalis anhydrica, aromatica beerengeschmack alcohol benzylicus 0.00078 mg cum propylenglycolum 0.036 mg cum pro compresso. - onkologikum - synthetika
tollwut impfstoff mérieux poudre et solvant pour suspension injectable
sanofi-aventis (suisse) sa - virus rabiei inactivatus (souche: wistar rabbia pm/wi 38-1503-3m) - poudre et solvant pour suspension injectable - praeparatio cryodesiccata: virus rabiei inactivatus (souche: wistar rabies pm/wi 38-1503-3m) min. 2.5 u.i., albuminum humanum, pro vase, residui: neomycini sulfas, phenolsulfonphthaleinum. solvens: aqua ad iniectabile q.s. ad solutionem pro 1 ml. - immunizzazione attiva contro la rabbia - vaccini